Efficacy and safety of olanzapine in the treatment of patients with bipolar I disorder, depressed: a randomized, double-blind comparison with placebo.
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Olanzapine (Primary)
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 23 Aug 2012 Results published in the British Journal of Psychiatry.
- 12 Aug 2010 Actual end date (July 2010) added as reported by ClinicalTrials.gov.
- 12 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.